JP2013501794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013501794A5 JP2013501794A5 JP2012524779A JP2012524779A JP2013501794A5 JP 2013501794 A5 JP2013501794 A5 JP 2013501794A5 JP 2012524779 A JP2012524779 A JP 2012524779A JP 2012524779 A JP2012524779 A JP 2012524779A JP 2013501794 A5 JP2013501794 A5 JP 2013501794A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- age
- treatment
- group
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *c1n[s]c(Nc2c(C(F)(F)F)cccc2)c1C#N Chemical compound *c1n[s]c(Nc2c(C(F)(F)F)cccc2)c1C#N 0.000 description 1
- PQUYRYUQEJSMJA-CMDGGOBGSA-N C/C(/Nc(cccc1)c1Cl)=C(\C(\O)=N/C)/C#N Chemical compound C/C(/Nc(cccc1)c1Cl)=C(\C(\O)=N/C)/C#N PQUYRYUQEJSMJA-CMDGGOBGSA-N 0.000 description 1
- XJAZKOSALONURY-UHFFFAOYSA-N N#CC(C(O)=NC1)=C1Nc(cc1)ccc1Cl Chemical compound N#CC(C(O)=NC1)=C1Nc(cc1)ccc1Cl XJAZKOSALONURY-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23304709P | 2009-08-11 | 2009-08-11 | |
| US61/233,047 | 2009-08-11 | ||
| PCT/US2010/044946 WO2011019678A1 (en) | 2009-08-11 | 2010-08-10 | Isothiozoles for treating conditions of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013501794A JP2013501794A (ja) | 2013-01-17 |
| JP2013501794A5 true JP2013501794A5 (enExample) | 2013-10-03 |
Family
ID=43007053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012524779A Abandoned JP2013501794A (ja) | 2009-08-11 | 2010-08-10 | 目の疾患を治療するためのイソチオゾール |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110039900A1 (enExample) |
| EP (1) | EP2464351A1 (enExample) |
| JP (1) | JP2013501794A (enExample) |
| KR (1) | KR20120081585A (enExample) |
| CN (1) | CN102695505A (enExample) |
| AU (1) | AU2010282698A1 (enExample) |
| BR (1) | BR112012003284A8 (enExample) |
| CA (1) | CA2770894A1 (enExample) |
| IN (1) | IN2012DN01846A (enExample) |
| RU (1) | RU2012105453A (enExample) |
| WO (1) | WO2011019678A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA56220A (fr) | 2014-09-17 | 2022-04-20 | Panoptica Inc | Formulations oculaires permettant l'administration de médicament et la protection du segment antérieur de l'oeil |
| IL251949A0 (en) | 2017-04-26 | 2017-07-31 | Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct | Small organic molecules for use in the treatment of neuro-inflammatory diseases |
| EP3897670A4 (en) | 2018-12-19 | 2022-09-07 | Disarm Therapeutics, Inc. | MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US6989451B2 (en) * | 2002-06-04 | 2006-01-24 | Valeant Research & Development | Heterocyclic compounds and uses thereof |
| AR051248A1 (es) * | 2004-10-20 | 2007-01-03 | Applied Research Systems | Derivados de 3-arilamino piridina |
| CN101505744A (zh) * | 2006-07-25 | 2009-08-12 | 爱尔康研究有限公司 | 用于预防和治疗眼部病症的内皮分化基因亚家庭3（edg-3，s1p3）受体的拮抗剂 |
-
2010
- 2010-08-10 RU RU2012105453/15A patent/RU2012105453A/ru not_active Application Discontinuation
- 2010-08-10 JP JP2012524779A patent/JP2013501794A/ja not_active Abandoned
- 2010-08-10 AU AU2010282698A patent/AU2010282698A1/en not_active Withdrawn
- 2010-08-10 WO PCT/US2010/044946 patent/WO2011019678A1/en not_active Ceased
- 2010-08-10 IN IN1846DEN2012 patent/IN2012DN01846A/en unknown
- 2010-08-10 CN CN2010800456300A patent/CN102695505A/zh active Pending
- 2010-08-10 BR BR112012003284A patent/BR112012003284A8/pt not_active IP Right Cessation
- 2010-08-10 CA CA2770894A patent/CA2770894A1/en not_active Abandoned
- 2010-08-10 EP EP10742992A patent/EP2464351A1/en not_active Withdrawn
- 2010-08-10 US US12/853,914 patent/US20110039900A1/en not_active Abandoned
- 2010-08-10 KR KR1020127006129A patent/KR20120081585A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011518833A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| MX343620B (es) | Forma polimorfica de clorhidrato de pridopidina. | |
| JP2013525444A5 (enExample) | ||
| EP4241772A3 (en) | Process for the preparation of compounds useful for treating spinal muscular atrophy | |
| EA201301181A1 (ru) | Триазолопиридины | |
| BR112014003225A2 (pt) | profármacos de treprostinil ligados a veículo | |
| JP2011105738A5 (enExample) | ||
| WO2010048332A3 (en) | Compounds for treating ophthalmic diseases and disorders | |
| WO2016020320A8 (en) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
| JP2011516477A5 (enExample) | ||
| JP2009149903A5 (enExample) | ||
| EA201270575A1 (ru) | Соединения | |
| EA201200794A1 (ru) | Триазолопиридины | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| EA201491028A8 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| JP2017514910A5 (enExample) | ||
| IN2012DN02139A (enExample) | ||
| PH12013500301A1 (en) | Oxadiazole inhibitors of leukotriene production | |
| JP2013523846A5 (enExample) | ||
| WO2013061004A8 (fr) | Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines | |
| TN2014000112A1 (en) | Ep1 receptor ligands | |
| JP2016540749A5 (enExample) | ||
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением |